Caliway’s drug molecule CBL-514 to treat Dercum’s disease receives EMA orphan drug designation: New Taipei City Thursday, November 14, 2024, 16:00 Hrs [IST] Caliway Biopharmac ...

Caliway Biopharmaceuticals (Caliway) announced that the European Medicines Agency (EMA) granted Orphan Drug Designation (ODD) to its novel small molecule drug, CBL-514, for the treatment of Dercum's ...

Dimension Capital Management LLC recently decreased its stake in Apple (AAPL, Financial), as revealed by the company's latest ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Japan’s biggest banks raised their annual profit forecasts to fresh records and unveiled plans to buy back shares, reaping ...

Researchers developed CpGPT, a novel foundation model for DNA methylation analysis that captures sequence, positional, and ...

Why have one review when you can have three? Here, Claudia Ross wonders if military technology has influenced the foundations ...

Revenue for the third quarter of 2024 was $1.8 million compared to $1.7 million for the same period in the prior year, an ...

This valuable study investigates how the neural representation of individual finger movements changes during the early period of sequence learning. By combining a new method for extracting features ...

A new white paper from Monash Business School has confirmed the essential role large-scale electricity storage will need to ...